These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 1548061)

  • 1. Phagocytic killing of encapsulated and microencapsulated Staphylococcus aureus by human polymorphonuclear leukocytes.
    Xu S; Arbeit RD; Lee JC
    Infect Immun; 1992 Apr; 60(4):1358-62. PubMed ID: 1548061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes.
    Peterson PK; Wilkinson BJ; Kim Y; Schmeling D; Quie PG
    Infect Immun; 1978 Mar; 19(3):943-9. PubMed ID: 640738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model.
    Thakker M; Park JS; Carey V; Lee JC
    Infect Immun; 1998 Nov; 66(11):5183-9. PubMed ID: 9784520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clindamycin at subinhibitory concentrations enhances antibody- and complement-dependent phagocytosis by human polymorphonuclear leukocytes of Staphylococcus aureus.
    Veringa EM; Verhoef J
    Chemotherapy; 1987; 33(4):243-9. PubMed ID: 3608624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dichotomy between opsonization and serum complement activation by encapsulated staphylococci.
    Peterson PK; Kim Y; Wilkinson BJ; Schmeling D; Michael AF; Quie PG
    Infect Immun; 1978 Jun; 20(3):770-5. PubMed ID: 352958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a factor released by K562 malignant cells in culture on human neutrophil bactericidal activity.
    Amar M; Amit N; Babin-Chevaye C; Huu TP; Hakim J
    Infect Immun; 1991 Aug; 59(8):2673-6. PubMed ID: 1855986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phagocytosis, bacterial killing, and metabolism by purified human lung phagocytes.
    Hoidal JR; Schmeling D; Peterson PK
    J Infect Dis; 1981 Jul; 144(1):61-71. PubMed ID: 7021701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsonic activity of normal human cerebrospinal fluid for selected bacterial species.
    Tofte RW; Peterson PK; Kim Y; Quie PG
    Infect Immun; 1979 Dec; 26(3):1093-8. PubMed ID: 43289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phagocytosis and killing of A-protein positive Staphylococcus aureus in the presence of low doses of antibiotics.
    Mascellino MT; De Vito ML; Maclean Feeney E; Iegri F; Catania S
    Drugs Exp Clin Res; 1989; 15(2):63-9. PubMed ID: 2737081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.
    Verhoef J; Peterson P; Kim Y; Sabath LD; Quie PG
    Immunology; 1977 Aug; 33(2):191-7. PubMed ID: 415969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological specificity of heat-stable opsonins in immune and nonimmune sera and their interaction with non-encapsulated and encapsulated strains of Staphylococcus aureus.
    Karakawa WW; Young DA
    Infect Immun; 1979 Jul; 25(1):175-86. PubMed ID: 478633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytosis and destruction of Staphylococcus aureus.
    Verbrugh HA
    Vet Q; 1981 Apr; 3(2):91-7. PubMed ID: 7245175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of the third component of complement on the cell wall of encapsulated Staphylococcus aureus M: implications for the mechanism of resistance to phagocytosis.
    Wilkinson BJ; Sisson SP; Kim Y; Peterson PK
    Infect Immun; 1979 Dec; 26(3):1159-63. PubMed ID: 393630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The key role of peptidoglycan in the opsonization of Staphylococcus aureus.
    Peterson PK; Wilkinson BJ; Kim Y; Schmeling D; Douglas SD; Quie PG; Verhoef J
    J Clin Invest; 1978 Mar; 61(3):597-609. PubMed ID: 641141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of human neutrophils and serum to host defense against Legionella micdadei.
    Weinbaum DL; Bailey J; Benner RR; Pasculle AW; Dowling JN
    J Infect Dis; 1983 Sep; 148(3):510-7. PubMed ID: 6619577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opsonizing effect of normal cerebrospinal fluid on Staphylococcus aureus.
    Hou SC; Ho ST; Shaio MF
    J Formos Med Assoc; 1990 Nov; 89(11):977-81. PubMed ID: 1982130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular and bacterial factors influencing staphylococcal phagocytosis and killing by human polymorphonuclear leukocytes.
    Peterson PK; Verhoef J; Sabath LD; Quie PG
    Infect Immun; 1976 Aug; 14(2):496-501. PubMed ID: 971959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers.
    Wilkinson BJ; Peterson PK; Quie PG
    Infect Immun; 1979 Feb; 23(2):502-8. PubMed ID: 422250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.